hydroxyurea - Generic mfg.
pevonedistat (MLN4924) - Takeda
Venclexta (venetoclax) - Roche, AbbVie
BI 836858 - Boehringer Ingelheim
SRA515 - GSK
Xospata (gilteritinib) - Astellas
dubermatinib (TP-0903) - Sumitomo Pharma
Tibsovo (ivosidenib) - Servier
azacitidine - Generic mfg.
decitabine - Generic mfg.
cytarabine - Generic mfg.
Idhifa (enasidenib) - BMS, Servier
entospletinib (GS-9973) - Ignota Labs
Revuforj (revumenib) - Syndax Pharma
lomonitinib (ZE46-0134) - Eilean Therap
ficlatuzumab (AV-299) - LG Chem
AZD5991 - AstraZeneca
daunorubicin - Generic mfg.
samalizumab (ALXN 6000) - The Leukemia & Lymphoma Society, AstraZeneca
http://clinicaltrials.gov/ct2/show/NCT03013998
 
Dec 18, 2025
 
Next